309 related articles for article (PubMed ID: 22768439)
21. [Actinic keratoses].
Hommel T; Szeimies RM
Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
[TBL] [Abstract][Full Text] [Related]
22. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
23. Actinic keratosis: review of the literature and new patents.
Cantisani C; De Gado F; Ulrich M; Bottoni U; Iacobellis F; Richetta AG; Calvieri S
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):168-75. PubMed ID: 23470197
[TBL] [Abstract][Full Text] [Related]
24. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
25. Actinic keratosis: facts and controversies.
Ko CJ
Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
[TBL] [Abstract][Full Text] [Related]
26. Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.
Heppt MV; Steeb T; Ruzicka T; Berking C
Br J Dermatol; 2019 Apr; 180(4):740-748. PubMed ID: 30447074
[TBL] [Abstract][Full Text] [Related]
27. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
28. Safety of topical interventions for the treatment of actinic keratosis.
Koch EAT; Wessely A; Steeb T; Berking C; Heppt MV
Expert Opin Drug Saf; 2021 Jul; 20(7):801-814. PubMed ID: 33834933
[No Abstract] [Full Text] [Related]
29. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
30. The importance of early diagnosis and treatment of actinic keratosis.
Rigel DS; Stein Gold LF
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S20-7. PubMed ID: 23228303
[TBL] [Abstract][Full Text] [Related]
31. [Actinic Keratosis].
Dejaco D; Hauser U; Zelger B; Riechelmann H
Laryngorhinootologie; 2015 Jul; 94(7):467-79; quiz 480-1. PubMed ID: 26125293
[TBL] [Abstract][Full Text] [Related]
32. [When and why treat actinic keratoses?].
Wulf HC
Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
[TBL] [Abstract][Full Text] [Related]
33. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
34. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
35. Emerging drugs for actinic keratosis.
Ulrich M; Drecoll U; Stockfleth E
Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
[TBL] [Abstract][Full Text] [Related]
36. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
37. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
38. Current issues in the management of actinic keratosis.
Ceilley RI; Jorizzo JL
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
[TBL] [Abstract][Full Text] [Related]
39. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma.
Newman MD; Weinberg JM
Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492
[TBL] [Abstract][Full Text] [Related]
40. Investigational drugs currently in phase II clinical trials for actinic keratosis.
Lozzi F; Lanna C; Mazzeo M; Garofalo V; Palumbo V; Mazzilli S; Diluvio L; Terrinoni A; Bianchi L; Campione E
Expert Opin Investig Drugs; 2019 Jul; 28(7):629-642. PubMed ID: 31232099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
